Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Mark Forrest Gordon
Based on 11 articles published since 2010
(Why 11 articles?)
||||
Expertise Level
The expertise of Mark Forrest Gordon ranks in the
  • Top 1.8%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Aliases Gordon, Mark F   ·   Gordon, Mark Forrest
Work Locations
Details
Most likely:    Boehringer Ingelheim      
2019
  • VTT Technical Research Centre of Finland Ltd, Tampere, Finland. · Combinostics Ltd, Tampere, Finland. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Current affiliation: Teva Pharmaceuticals, Inc., Frazer, PA, USA. · Pubmed 30909211
2018
  • Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands. · University Hospital Leuven, Leuven, Belgium. · Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · AP-HM, CHU Timone, CIC CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France. · Neurosciences Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage, UK. · U1171 Inserm, CHU Lille, Degenerative and Vascular Cognitive Disorders, University of Lille, Lille, France. · Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section for Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden. · Barcelona βeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium. · Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, Antwerp, Belgium. · Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology, Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain. · Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland. · Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolau" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. · University of Oxford, Oxford, UK. · King's College London, London, UK. · Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lubeck, Germany. · School of Public Health, Imperial College London, London, UK. · Department of Psychology, University of Oslo, Oslo, Norway. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · UCB Biopharma SPRL, Braine-l'Alleud, Belgium. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · MAAT, Archamps, France. · Teva Pharmaceuticals, Inc., Malvern, PA, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA. · Department of Radiology and Nuclear Medicine, VUMC, Amsterdam, the Netherlands. · University of Geneva, Geneva, Switzerland. · Institutes of Neurology and Healthcare Engineering, UCL, London, UK. · Pubmed 30261928
  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands. · Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. · Department of Radiology and Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. · Department of Neurology, Memory and Aging Center, University of California, San Francisco. · Helen Wills Neuroscience Institute, University of California, Berkeley. · Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St Louis, Missouri. · Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden. · Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. · Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands. · Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia. · Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals, and University of Geneva, Geneva, Switzerland. · Banner Alzheimer's Institute, Phoenix, Arizona. · Eli Lilly and Company, Indianapolis, Indiana. · Department of Neurosciences, University of California, San Diego. · Neurology Department, Hospital de Sant Pau, Barcelona, Spain. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. · Institut National de la Santé et de la Recherche Médicale (INSERM), CHU de Caen, Caen, France. · Alzheimer's Disease and Other Cognitive Disorders Unit, IDIBAPS, Clinic University Hospital, Barcelona, Spain. · Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. · Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany. · Section of Neurology, Center for Memory Disturbances, University of Perugia, Perugia, Italy. · Department of Psychiatry, Service of Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Neurology, Akershus University Hospital, Lørenskog, Norway. · Department of Neuropsychiatry, Seoul National University, College of Medicine, Seoul, South Korea. · Laboratory for Cognitive Neurology and Alzheimer Research Centre KU Leuven, Catholic University Leuven, Leuven, Belgium. · Center for Neuroscience and Cell Biology, Faculty of Medicine, Centro Hospitalar e Universitário de Coimbra, Portugal. · First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. · Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. · Memory Clinic and Neurochemistry Laboratory, Saint Luc University Hospital, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium. · Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland. · Departments of Neurology and Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, the Netherlands. · Neurology Service, Universitary Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain. · Center for Neurology, Hospital of Bremen-Ost, Bremen, Germany. · CHRU de Tours, CIC INSERM 1415, INSERM U930, and Université François Rabelais de Tours, Tours, France. · Alzheimer Center, Wroclaw Medical University, Scinawa, Poland. · Division of Neuroscience, Medical Research Council Clinical Sciences Centre, Imperial College London, London, England. · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Turku PET Centre and Division of Clinical Neurosciences Turku, University of Turku and Turku University Hospital, Turku, Finland. · Myrna Brind Center of Integrative Medicine, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania. · Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Lisbon, Portugal. · Neurologie de la Mémoire et du Langage, Centre Hospitalier Sainte-Anne, Université Paris 5, Paris, France. · Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Cognitive Impairments, University Medical Centre Ljubljana, Ljubljana, Slovenia. · Department NVS, Center for Alzheimer Research, Translational Alzheimer Neurobiology, Karolinska Institutet, and Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden. · Lui Che Woo Institute of Innovative Medicine, Department of Medicine and Therapeutics, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong. · Department of Neurodegeneration Diagnostics, Leading National Research Centre in Białystok (KNOW), Medical University of Białystok, Białystok, Poland. · Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany. · Third Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Roche Products, Welwyn Garden City, United Kingdom. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands. · Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Stijmsalpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière, Paris, France. · Department of Nuclear Medicine, Technische Universitaet München, Munich, Germany. · Danish Dementia Research Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark. · Department of Geriatrics, Karolinska University Hospital Huddinge, Section of Clinical Geriatrics, Institution of NVS, Karolinska Institutet, Stockholm, Sweden. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut. · Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitaet München, Munich, Germany. · Department of Psychiatry, Alzheimer Memorial Center and Geriatric Psychiatry Branch, Ludwig-Maximilian University, Munich, Germany. · Center of Geriatrics and Gerontology, University Hospital Freiburg, Freiburg, Germany. · Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. · Memory Clinic, Danish Dementia Research Center, Rigshospitalet, Copenhagen, Denmark. · Jagiellonian University College of Medicine, Krakow, Poland. · Piramal Imaging GmbH, Berlin, Germany. · Department of Imaging and Pathology, Catholic University Leuven, Leuven, Belgium. · School of Medicine, Center for Brain Health, New York University, New York. · Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · Geriatric Medicine, Department of Clinical and Experimental Medicine, University of Linköping, Linköping, Sweden. · Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, the Netherlands. · Janssen Research and Development, Titusville, New Jersey. · Department of Psychological Medicine, Institute of Psychiatry, Kings College London, London, United Kingdom. · Department of Psychiatry and Psychotherapy, Charité Berlin, German Center for Neurodegenrative Diseases (DZNE), Berlin, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center, Georg-August University, Göttingen, Germany. · Sektion Gerontopsychiatrie, Universität Heidelberg, Heidelberg, Germany. · Department of Geriatrics-Gerontology-Gerontopsychiatry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. · Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands. · UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 29188296
2017
  • Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · Roche Diagnostics, Basel, Switzerland. · University of California, Davis, CA, USA. · Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · AbbVie, Abbott Park, IL, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Eisai, Woodcliff Lake, NJ, USA. · Novartis, East Hanover, NJ, USA. · Icon, Warrington, PA, USA. · Janssen R&D, Raritan, NJ, USA. · Merck, Rahway, NJ, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Meso Scale Diagnostics, LLC, Rockville, MD, USA. · Biomarkable, Gent, Belgium. · Genentech/Roche, San Francisco, CA, USA. · Pubmed 27662307
  • 1 Janssen Research & Development, LLC, San Francisco, CA, USA. · 2 Neurology Department, Loma Linda University School of Medicine, Loma Linda, CA, USA. · 3 AstraZeneca Neuroscience iMed, Cambridge, MA, USA (until September 2014), Consultant, Rockville, MD, USA (until October 2016). · 4 Pentara Corporation, Salt Lake City, UT, USA. · 5 Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. · 6 Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA. · 7 Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA. · 8 Alzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA. · Pubmed 30231712
  • Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands. Electronic address: · Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands. · On behalf of German Dementia Competence Network; Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University Medical Center (UMC), Georg-August-University, Göttingen, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium; Department of Clinical and Lifespan Psychology, Vrije Universiteit Brussel, Brussels, Belgium. · 3rd Department of Neurology, Aristotle University of Thessaloniki, Memory and Dementia Center, "G Papanicolau" General Hospital, Thessaloniki, Greece. · Division of Clinical Geriatrics, Department of Neurobiology, Caring Sciences and Society (NVS), Karolinska Institutet, Huddinge, Sweden; Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden. · Danish Dementia Research Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Neurology, University of Hospital Leuven, Leuven, Belgium; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Belgium. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · On behalf of the EADC-PET consortium; Geneva Neuroscience Center, University Hospital and University of Geneva, Geneva, Switzerland; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · On behalf of the EADC-PET consortium; Clinical Neurology, Department of Neurosciences (DINOGMI), University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy. · On behalf of the EADC-PET consortium; Nuclear Medicine, Department of Health Science (DISSAL), University of Genoa IRCCS AOU San Martino-IST, Genoa, Italy. · On behalf of the EADC-PET consortium; Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · On behalf of the EADC-PET consortium; AP-HM Hôpitaux de la Timone, Service de Neurologie et Neuropsychologie, Marseille, France; Aix-Marseille Université, INSERM, Institut de Neurosciences des Systèmes, Marseille, France. · On behalf of the EADC-PET consortium; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands. · Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium; GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium. · GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium. · Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium. · Center for Neuroscience and Cell Biology, Faculty of Medicine, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. · Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Real World Data Science (RWD-S) Neuroscience and Established Products, F. Hoffmann-La Roche Ltd. Pharmaceuticals Division, Basel, Switzerland. · PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK; Epidemiologische Beratung und Literatur-Recherche "conepi", Herrsching, Germany. · PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. · Department of Clinical Sciences Malmö, Lund University, Clinical Memory Research Unit, Lund, Sweden. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, AXA Research Fund & UPMC Chair, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, 47 Boulevard de l'Hôpital, Paris, CEDEX 13, France. · Institute of Clinical Medicine, Neurology, University of Eastern Finland and Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland. · Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Pubmed 28482212
2016
  • Orion Bionetworks, Inc., Cambridge, MA, USA. Electronic address: · C-Path Institute, Tucson, AZ, USA. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · Prize4Life, Tel Aviv, Israel. · In Silico Biosciences, Berwyn, PA, USA. · Pubmed 27327540
  • In Silico Biosciences, Inc., Berwyn, PA, USA. Electronic address: · Alzheimer's Drug Discovery Foundation, New York, NY, USA. · Exploratory Statistics, AbbVie, Souderton, PA, USA. · Orion Bionetworks, Inc., Cambridge MA, USA. · PAD2020, Potomac, MD, USA. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · VIB Department of Molecular Genetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · C-Path Institute, Tucson, AZ, USA. · Pubmed 27238630
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. Electronic address: · Evidera, formerly United BioSource Corporation (UBC), Lexington, MA, USA. · Xcenda, Palm Harbor, FL, USA. · Merck, Kenilworth, NJ, USA. · Outcometrix, Tucson, AZ, USA. · Bracket, Wayne, PA, USA. · Genentech, South San Francisco, CA, USA. · Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA. · University of California, San Diego, School of Medicine, San Diego, CA, USA. · McGill Centre for Studies in Aging, Montreal, Canada. · Patient-Centered Outcomes Research Institute (PCORI), Washington, D.C, USA. · Pubmed 26079412
2013
  • 1 Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · 2 Independent science writer, Elverson, PA, USA. · 3 Alzheimer's Association, Chicago, IL, USA. · 4 Pfizer Inc, New London, CT, USA. · 5 Arizona State University, Phoenix, AZ, USA. · 6 Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · 7 Mayo Clinic, Rochester, MN, USA. · 8 Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · 9 Eisai Inc, Woodcliff Lake, NJ, USA. · 10 Institute for Neurodegenerative Disorders, New Haven, CT, USA. · 11 Metrum Research Group, Tariffville, CT, USA. · Current affiliation: Synergia Consulting, MI, USA. · 12 Johnson & Johnson, Raritan, NJ, USA. · 13 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 14 US Food and Drug Administration, Silver Spring, MD, USA. · 15 USAgainst Alzheimer's, Washington, DC, USA. · 16 European Medicines Agency (EMA), London, UK. · Pubmed 30235546
Probable:    Teva Pharmaceutical Industries      
2019
  • VTT Technical Research Centre of Finland Ltd, Tampere, Finland. · Combinostics Ltd, Tampere, Finland. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Current affiliation: Teva Pharmaceuticals, Inc., Frazer, PA, USA. · Pubmed 30909211
2018
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, PO Box 7057, 1007, MB, Amsterdam, the Netherlands. · Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, PO Box 7057, 1007, MB, Amsterdam, the Netherlands. · Wolfson Molecular Imaging Centre, Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK. · Department of Ophthalmology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Geriatric Medicine, Spaarne Gasthuis, Haarlem, The Netherlands. · Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands. · Department of Psychiatry, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Geriatric Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Geriatric Medicine, MC Slotervaart Hospital, Amsterdam, The Netherlands. · Department of Geriatric Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. · Teva Pharmaceuticals, North Wales, Pennsylvania, USA. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim International GmbH, Ingelheim/Rhein, Germany. · Department of Internal Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Clinical Neurophysiology and MEG Center, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Dutch Connectome Lab, Department of Complex Trait Genetics, Center for Neuroscience and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Otolaryngology-Head and Neck Surgery, Section Ear & Hearing, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Neurochemistry Laboratory, Department of Clinical chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Institutes of Neurology and Healthcare Engineering, University College London, London, UK. · Department of Medicine and Aged Care, @AgeMelbourne, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. · Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. · Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. · Pubmed 30477432
  • Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands. · University Hospital Leuven, Leuven, Belgium. · Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · AP-HM, CHU Timone, CIC CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France. · Neurosciences Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage, UK. · U1171 Inserm, CHU Lille, Degenerative and Vascular Cognitive Disorders, University of Lille, Lille, France. · Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section for Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden. · Barcelona βeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium. · Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, Antwerp, Belgium. · Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology, Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain. · Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland. · Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolau" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. · University of Oxford, Oxford, UK. · King's College London, London, UK. · Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lubeck, Germany. · School of Public Health, Imperial College London, London, UK. · Department of Psychology, University of Oslo, Oslo, Norway. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · UCB Biopharma SPRL, Braine-l'Alleud, Belgium. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · MAAT, Archamps, France. · Teva Pharmaceuticals, Inc., Malvern, PA, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA. · Department of Radiology and Nuclear Medicine, VUMC, Amsterdam, the Netherlands. · University of Geneva, Geneva, Switzerland. · Institutes of Neurology and Healthcare Engineering, UCL, London, UK. · Pubmed 30261928
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Mark Forrest Gordon about Alzheimer Disease:

  • Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease. 2019
  • Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. 2018
  • MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. 2018
  • Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. 2018
  • Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team. 2017
  • Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients. 2017
  • The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. 2017
  • Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation. 2016
  • Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge. 2016
  • Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. 2016
Show List of Full Article Records
Google Searches

Learn more about Mark Forrest Gordon using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Boehringer Ingelheim
Teva Pharmaceutical Industries
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Boehringer Ingelheim
2019
  • VTT Technical Research Centre of Finland Ltd, Tampere, Finland. · Combinostics Ltd, Tampere, Finland. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Current affiliation: Teva Pharmaceuticals, Inc., Frazer, PA, USA. · Pubmed 30909211
2018
  • Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands. · University Hospital Leuven, Leuven, Belgium. · Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · AP-HM, CHU Timone, CIC CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France. · Neurosciences Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage, UK. · U1171 Inserm, CHU Lille, Degenerative and Vascular Cognitive Disorders, University of Lille, Lille, France. · Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section for Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden. · Barcelona βeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium. · Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, Antwerp, Belgium. · Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology, Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain. · Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland. · Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolau" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. · University of Oxford, Oxford, UK. · King's College London, London, UK. · Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lubeck, Germany. · School of Public Health, Imperial College London, London, UK. · Department of Psychology, University of Oslo, Oslo, Norway. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · UCB Biopharma SPRL, Braine-l'Alleud, Belgium. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · MAAT, Archamps, France. · Teva Pharmaceuticals, Inc., Malvern, PA, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA. · Department of Radiology and Nuclear Medicine, VUMC, Amsterdam, the Netherlands. · University of Geneva, Geneva, Switzerland. · Institutes of Neurology and Healthcare Engineering, UCL, London, UK. · Pubmed 30261928
  • Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands. · Department of Neurology and Alzheimer Center, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. · Department of Radiology and Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. · Department of Neurology, Memory and Aging Center, University of California, San Francisco. · Helen Wills Neuroscience Institute, University of California, Berkeley. · Knight Alzheimer's Disease Research Center, Department of Neurology, Washington University School of Medicine, St Louis, Missouri. · Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden. · Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. · Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands. · Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia. · Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Memory Clinic and LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals, and University of Geneva, Geneva, Switzerland. · Banner Alzheimer's Institute, Phoenix, Arizona. · Eli Lilly and Company, Indianapolis, Indiana. · Department of Neurosciences, University of California, San Diego. · Neurology Department, Hospital de Sant Pau, Barcelona, Spain. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. · Institut National de la Santé et de la Recherche Médicale (INSERM), CHU de Caen, Caen, France. · Alzheimer's Disease and Other Cognitive Disorders Unit, IDIBAPS, Clinic University Hospital, Barcelona, Spain. · Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. · Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany. · Section of Neurology, Center for Memory Disturbances, University of Perugia, Perugia, Italy. · Department of Psychiatry, Service of Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Neurology, Akershus University Hospital, Lørenskog, Norway. · Department of Neuropsychiatry, Seoul National University, College of Medicine, Seoul, South Korea. · Laboratory for Cognitive Neurology and Alzheimer Research Centre KU Leuven, Catholic University Leuven, Leuven, Belgium. · Center for Neuroscience and Cell Biology, Faculty of Medicine, Centro Hospitalar e Universitário de Coimbra, Portugal. · First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. · Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. · Memory Clinic and Neurochemistry Laboratory, Saint Luc University Hospital, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium. · Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland. · Departments of Neurology and Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, the Netherlands. · Neurology Service, Universitary Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain. · Center for Neurology, Hospital of Bremen-Ost, Bremen, Germany. · CHRU de Tours, CIC INSERM 1415, INSERM U930, and Université François Rabelais de Tours, Tours, France. · Alzheimer Center, Wroclaw Medical University, Scinawa, Poland. · Division of Neuroscience, Medical Research Council Clinical Sciences Centre, Imperial College London, London, England. · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Turku PET Centre and Division of Clinical Neurosciences Turku, University of Turku and Turku University Hospital, Turku, Finland. · Myrna Brind Center of Integrative Medicine, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania. · Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Lisbon, Portugal. · Neurologie de la Mémoire et du Langage, Centre Hospitalier Sainte-Anne, Université Paris 5, Paris, France. · Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Cognitive Impairments, University Medical Centre Ljubljana, Ljubljana, Slovenia. · Department NVS, Center for Alzheimer Research, Translational Alzheimer Neurobiology, Karolinska Institutet, and Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden. · Lui Che Woo Institute of Innovative Medicine, Department of Medicine and Therapeutics, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong. · Department of Neurodegeneration Diagnostics, Leading National Research Centre in Białystok (KNOW), Medical University of Białystok, Białystok, Poland. · Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany. · Third Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Roche Products, Welwyn Garden City, United Kingdom. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands. · Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Stijmsalpêtrière, Boulevard de l'hôpital, F-75013, Paris, France. · AXA Research Fund & UPMC Chair, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière, Paris, France. · Department of Nuclear Medicine, Technische Universitaet München, Munich, Germany. · Danish Dementia Research Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark. · Department of Geriatrics, Karolinska University Hospital Huddinge, Section of Clinical Geriatrics, Institution of NVS, Karolinska Institutet, Stockholm, Sweden. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut. · Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitaet München, Munich, Germany. · Department of Psychiatry, Alzheimer Memorial Center and Geriatric Psychiatry Branch, Ludwig-Maximilian University, Munich, Germany. · Center of Geriatrics and Gerontology, University Hospital Freiburg, Freiburg, Germany. · Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. · Memory Clinic, Danish Dementia Research Center, Rigshospitalet, Copenhagen, Denmark. · Jagiellonian University College of Medicine, Krakow, Poland. · Piramal Imaging GmbH, Berlin, Germany. · Department of Imaging and Pathology, Catholic University Leuven, Leuven, Belgium. · School of Medicine, Center for Brain Health, New York University, New York. · Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · Geriatric Medicine, Department of Clinical and Experimental Medicine, University of Linköping, Linköping, Sweden. · Department of Geriatric Medicine, Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, the Netherlands. · Janssen Research and Development, Titusville, New Jersey. · Department of Psychological Medicine, Institute of Psychiatry, Kings College London, London, United Kingdom. · Department of Psychiatry and Psychotherapy, Charité Berlin, German Center for Neurodegenrative Diseases (DZNE), Berlin, Germany. · Department of Psychiatry and Psychotherapy, University Medical Center, Georg-August University, Göttingen, Germany. · Sektion Gerontopsychiatrie, Universität Heidelberg, Heidelberg, Germany. · Department of Geriatrics-Gerontology-Gerontopsychiatry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. · Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands. · UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 29188296
2017
  • Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · Roche Diagnostics, Basel, Switzerland. · University of California, Davis, CA, USA. · Clinical Neurochemistry Lab, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. · AbbVie, Abbott Park, IL, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Eisai, Woodcliff Lake, NJ, USA. · Novartis, East Hanover, NJ, USA. · Icon, Warrington, PA, USA. · Janssen R&D, Raritan, NJ, USA. · Merck, Rahway, NJ, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Meso Scale Diagnostics, LLC, Rockville, MD, USA. · Biomarkable, Gent, Belgium. · Genentech/Roche, San Francisco, CA, USA. · Pubmed 27662307
  • 1 Janssen Research & Development, LLC, San Francisco, CA, USA. · 2 Neurology Department, Loma Linda University School of Medicine, Loma Linda, CA, USA. · 3 AstraZeneca Neuroscience iMed, Cambridge, MA, USA (until September 2014), Consultant, Rockville, MD, USA (until October 2016). · 4 Pentara Corporation, Salt Lake City, UT, USA. · 5 Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. · 6 Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA. · 7 Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA. · 8 Alzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA. · Pubmed 30231712
  • Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands. Electronic address: · Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands. · On behalf of German Dementia Competence Network; Department of Geriatric Psychiatry, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, Mannheim, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University Medical Center (UMC), Georg-August-University, Göttingen, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University of Bonn, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany. · On behalf of German Dementia Competence Network; Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium. · Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium; Department of Clinical and Lifespan Psychology, Vrije Universiteit Brussel, Brussels, Belgium. · 3rd Department of Neurology, Aristotle University of Thessaloniki, Memory and Dementia Center, "G Papanicolau" General Hospital, Thessaloniki, Greece. · Division of Clinical Geriatrics, Department of Neurobiology, Caring Sciences and Society (NVS), Karolinska Institutet, Huddinge, Sweden; Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden. · Danish Dementia Research Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Neurology, University of Hospital Leuven, Leuven, Belgium; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Belgium. · Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · On behalf of the EADC-PET consortium; Geneva Neuroscience Center, University Hospital and University of Geneva, Geneva, Switzerland; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · On behalf of the EADC-PET consortium; Clinical Neurology, Department of Neurosciences (DINOGMI), University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy. · On behalf of the EADC-PET consortium; Nuclear Medicine, Department of Health Science (DISSAL), University of Genoa IRCCS AOU San Martino-IST, Genoa, Italy. · On behalf of the EADC-PET consortium; Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · On behalf of the EADC-PET consortium; AP-HM Hôpitaux de la Timone, Service de Neurologie et Neuropsychologie, Marseille, France; Aix-Marseille Université, INSERM, Institut de Neurosciences des Systèmes, Marseille, France. · On behalf of the EADC-PET consortium; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands. · Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium; GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium. · GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium. · Department of Neurology and Memory Clinic, CHU Liège, Liège, Belgium. · Center for Neuroscience and Cell Biology, Faculty of Medicine, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. · Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal. · Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Real World Data Science (RWD-S) Neuroscience and Established Products, F. Hoffmann-La Roche Ltd. Pharmaceuticals Division, Basel, Switzerland. · PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK; Epidemiologische Beratung und Literatur-Recherche "conepi", Herrsching, Germany. · PDB RWD (Real World Data) Team, Roche Products Limited, Welwyn Garden City, UK. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. · Department of Clinical Sciences Malmö, Lund University, Clinical Memory Research Unit, Lund, Sweden. · Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, AXA Research Fund & UPMC Chair, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) & Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, 47 Boulevard de l'Hôpital, Paris, CEDEX 13, France. · Institute of Clinical Medicine, Neurology, University of Eastern Finland and Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland. · Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, Netherlands; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Pubmed 28482212
2016
  • Orion Bionetworks, Inc., Cambridge, MA, USA. Electronic address: · C-Path Institute, Tucson, AZ, USA. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · Prize4Life, Tel Aviv, Israel. · In Silico Biosciences, Berwyn, PA, USA. · Pubmed 27327540
  • In Silico Biosciences, Inc., Berwyn, PA, USA. Electronic address: · Alzheimer's Drug Discovery Foundation, New York, NY, USA. · Exploratory Statistics, AbbVie, Souderton, PA, USA. · Orion Bionetworks, Inc., Cambridge MA, USA. · PAD2020, Potomac, MD, USA. · Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA. · VIB Department of Molecular Genetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · C-Path Institute, Tucson, AZ, USA. · Pubmed 27238630
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. Electronic address: · Evidera, formerly United BioSource Corporation (UBC), Lexington, MA, USA. · Xcenda, Palm Harbor, FL, USA. · Merck, Kenilworth, NJ, USA. · Outcometrix, Tucson, AZ, USA. · Bracket, Wayne, PA, USA. · Genentech, South San Francisco, CA, USA. · Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA. · University of California, San Diego, School of Medicine, San Diego, CA, USA. · McGill Centre for Studies in Aging, Montreal, Canada. · Patient-Centered Outcomes Research Institute (PCORI), Washington, D.C, USA. · Pubmed 26079412
2013
  • 1 Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · 2 Independent science writer, Elverson, PA, USA. · 3 Alzheimer's Association, Chicago, IL, USA. · 4 Pfizer Inc, New London, CT, USA. · 5 Arizona State University, Phoenix, AZ, USA. · 6 Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · 7 Mayo Clinic, Rochester, MN, USA. · 8 Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · 9 Eisai Inc, Woodcliff Lake, NJ, USA. · 10 Institute for Neurodegenerative Disorders, New Haven, CT, USA. · 11 Metrum Research Group, Tariffville, CT, USA. · Current affiliation: Synergia Consulting, MI, USA. · 12 Johnson & Johnson, Raritan, NJ, USA. · 13 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 14 US Food and Drug Administration, Silver Spring, MD, USA. · 15 USAgainst Alzheimer's, Washington, DC, USA. · 16 European Medicines Agency (EMA), London, UK. · Pubmed 30235546
Teva Pharmaceutical Industries
2019
  • VTT Technical Research Centre of Finland Ltd, Tampere, Finland. · Combinostics Ltd, Tampere, Finland. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Current affiliation: Teva Pharmaceuticals, Inc., Frazer, PA, USA. · Pubmed 30909211
2018
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, PO Box 7057, 1007, MB, Amsterdam, the Netherlands. · Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, PO Box 7057, 1007, MB, Amsterdam, the Netherlands. · Wolfson Molecular Imaging Centre, Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK. · Department of Ophthalmology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Geriatric Medicine, Spaarne Gasthuis, Haarlem, The Netherlands. · Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands. · Department of Psychiatry, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Geriatric Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Geriatric Medicine, MC Slotervaart Hospital, Amsterdam, The Netherlands. · Department of Geriatric Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. · Teva Pharmaceuticals, North Wales, Pennsylvania, USA. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · Boehringer Ingelheim International GmbH, Ingelheim/Rhein, Germany. · Department of Internal Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Clinical Neurophysiology and MEG Center, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Dutch Connectome Lab, Department of Complex Trait Genetics, Center for Neuroscience and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Otolaryngology-Head and Neck Surgery, Section Ear & Hearing, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Neurochemistry Laboratory, Department of Clinical chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Institutes of Neurology and Healthcare Engineering, University College London, London, UK. · Department of Medicine and Aged Care, @AgeMelbourne, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia. · Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. · Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. · Pubmed 30477432
  • Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands. · University Hospital Leuven, Leuven, Belgium. · Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Alzheimer Center & Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. · AP-HM, CHU Timone, CIC CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, Marseille, France. · Neurosciences Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage, UK. · U1171 Inserm, CHU Lille, Degenerative and Vascular Cognitive Disorders, University of Lille, Lille, France. · Sahlgrenska Academy, Institute of Neuroscience and Physiology, Section for Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden. · Barcelona βeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. · Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium. · Neurodegenerative Brain Diseases, Center for Molecular Neurology, VIB, Antwerp, Belgium. · Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Department of Neurology, Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain. · Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland. · Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland. · Memory and Dementia Center, 3rd Department of Neurology, "G Papanicolau" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. · University of Oxford, Oxford, UK. · King's College London, London, UK. · Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lubeck, Germany. · School of Public Health, Imperial College London, London, UK. · Department of Psychology, University of Oslo, Oslo, Norway. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · UCB Biopharma SPRL, Braine-l'Alleud, Belgium. · Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. · MAAT, Archamps, France. · Teva Pharmaceuticals, Inc., Malvern, PA, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Worldwide Research and Development, Pfizer Inc, Cambridge, MA, USA. · Department of Radiology and Nuclear Medicine, VUMC, Amsterdam, the Netherlands. · University of Geneva, Geneva, Switzerland. · Institutes of Neurology and Healthcare Engineering, UCL, London, UK. · Pubmed 30261928
Yearly article counts 01333001000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.